Veru (VERU) Construction in Progress (2012 - 2013)
Veru (VERU) posted quarterly Construction in Progress of $27796.0 for Q2 2013, down 92.42% year-over-year from $366934.0 in Q2 2012, and down 24.81% quarter-over-quarter from $36968.0 in Q1 2013.
Veru (VERU) Construction in Progress (2012 - 2013) Analysis & Trends
Veru (VERU) has reported Construction in Progress for 2 consecutive years, with $27796.0 the latest figure, recorded in Q2 2013.
- In Q2 2013, Construction in Progress fell 92.42% year-over-year to $27796.0; the TTM figure through Jun 2013 stood at $27796.0 (down 92.42% YoY), while the FY2012 annual figure was $268765.0, changed N/A from the prior year.
- Construction in Progress fell to $27796.0 in Q2 2013 per VERU's latest filing, from $36968.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $366934.0 in Q2 2012 and bottomed at $27796.0 in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 152.67 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Veru | 61.31 Mn | 35.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 27,796.00 |
| Mar 31, 2013 | 36,968.00 |
| Dec 31, 2012 | 285,214.00 |
| Sep 30, 2012 | 268,765.00 |
| Jun 30, 2012 | 366,934.00 |